Introduction
============

Gastric cancer (GC) is the fourth most common cancer nowadays as well as the second leading cause of cancer-deaths worldwide [@B1], [@B2]. *Helicobacter pylori* (*H. pylori,Hp*) infection is closely associated with GC [@B3]. However, the pathogenesis of GC with *Hp* infection is still not fully understood.

Post-transcriptional regulation of non-coding RNA plays an important role in the development of cancer, which has become a research focus involved in the pathogenesis of GC, including *Hp*-related GC [@B4]. A large number of studies have explored miRNA and lncRNA expression in *Hp* positive GC, suggesting that different pathogenesis mechanisms could exist between *Hp*-positive and *Hp*-negative GC [@B5], [@B6]. Recently, *Salmena* et al. (2011) put forward the hypothesis of competing endogenous RNA (ceRNA), which triggered a hot topic in the research field [@B7]. At present, the regulation of ceRNA network in tumor development has been found in colon cancer, ovarian cancer, and also GC [@B8]-[@B10]. However, the *Hp* related non-coding RNA regulation in GC is still at elementary stage and relevant ceRNA regulation in GC with and without *Hp* infection remains largely unclear.

Online public databases provide an available resource platform for data mining and research exploration. In this study, using online bioinformatics resources, we explored ceRNA regulatory network of GC with and without *Hp* infection and further detected relevant functional pathway and potential prognostic value of differential expressed genes based on ceRNA network. Meanwhile, we used real time-PCR validation for some of these bioinformatics analysis results in gastric cancer tissue with or without *Hp* infection. Our research might expend the understanding of the molecular mechanism of *Hp* positive GC.

Materials and methods
=====================

Acquisition and selection of datasets
-------------------------------------

A total of 443 patients with GC were collected from the Cancer Genome Atlas (TCGA) database (<https://gdc-portal.nci.nih.gov/>). According to the clinical data, patients without *Hp* information were excluded. A total of 188 patients were extracted from 443 data, including 20 *Hp* positive patients and 168 *Hp* negative patients. And the clinical parameters of these 188 cases were listed in supplementary file Table [S1](#SM0){ref-type="supplementary-material"}. The RNA expression profile data of the corresponding patients were downloaded from TCGA GDC data portal. Our study was in accordance with the publication guidelines provided by TCGA.

Identification of DEGs, DE-lncRNAs, DE-miRNAs
---------------------------------------------

Empirical Analysis of Digital Gene Expression Data in R (edger) package (<http://bioconductor.org/packages/release/bioc/html/edgeR.html>) were applied to screen out differentially expressed lncRNAs, mRNAs and miRNAs between GC with *Hp* infection and GC without *Hp* infection, using *P*\<0.01, \|fold change\|\>1 (including up-regulation and down-regulation) for miRNAs and *P*\<0.01, \|fold change\|\>2.5 for mRNA as cut-offs. Then we used BIOMART ([www.ensembl.org/biomart](http://www.ensembl.org/biomart)) to define and annotate the differentially expressed lncRNAs (DElncRNAs) from DERNAs. Fig. [1](#F1){ref-type="fig"} depicted the flow diagram of bioinformatics analysis.

Construction of ceRNA network
-----------------------------

We predicted DEmRNAs and DEmiRNA regulatory relationship through miRWalk 3.0 (<http://mirwalk.umm.uni-heidelberg.de/>) and TargetScanHuman 7.1 (<http://www.targetscan.org/vert_71/>), DEmiRNAs and DElncRNAs regulatory relationship through DIANA-LncBase v2 (<http://www.microrna.gr/LncBase>). Then we combined the results with differentially expressed data of TCGA to pick out the intersection mRNAs and lncRNAs. Next, we selected the intersectant DElncRNAs and DEmiRNAs which possess opposite expression trends, as well as DEmiRNAs and DEmRNAs. By this means, DElncRNAs and DEmRNAs regulated by the same DEmiRNAs were filtered out. The selected genes were chosen to construct the ceRNA network and visualized by Cytoscape software (<http://cytoscape.org/>) [@B11].

Functional enrichment analysis
------------------------------

We used the overlapping differentially expressed RNA to conduct the functional enrichment analysis on Database for Annotation, Visualization and Integrated Discovery (DAVID, <http://david.abcc.ncifcrf.gov/>), including GO annotation and KEGG pathway analysis [@B12]. And GO annotation contained biological process, molecular function and cellular component.

Protein-protein interaction (PPI) network construction
------------------------------------------------------

The Retrieval of Interacting Genes (STRING) database tool (string-db.org) was used to figure out the interactive relationships of DEGs. The interacting pairs with confidence score more than 0.4 were considered as significant and retained. Based on STRING results, PPI network was visualized utilizing Cytoscape software.

Survival analysis
-----------------

To identity the possible relationship of DElncRNAs and DEmiRNAs with GC prognosis, package "survival" of R was conducted to test the prognostic value, with clinical data of TCGA combined. This test is based on the Kaplan-Meier method and *P*\<0.05 would be considered as significant.

Real-time PCR validation of DElncRNAs
-------------------------------------

A total of 30 patients, including 23 men and 7 women, mean age of 62± 9 years old, with gastric cancer were enrolled for the validation, from whom cancerous gastric tissues were collected under gastrectomy at the First Affiliated Hospital of China Medical University. Total RNA was extracted using RNAiso Plus (Takara, Japan) and converted to cDNA using a PrimeScript RT reagent kit (Takara, Japan). The amplification was used with SYBR Green (SYBR Premix Ex Taq II, Takara, USA) in a fluorescence reader ABI Prism 7500. Each reaction was normalized to β-actin. All the primers are shown in supplementary table [2](#SM0){ref-type="supplementary-material"}. Fasting venous blood was collected from each participant and the status of *Hp* infection was determined by ASSURE H.Pylori Rapid Test (MP bio, USA). Among the 30 GC patients, 11 cases were without*Hp* infection and 19 ones with *Hp* infection. This study was approved by the Ethics Committee of the First Affiliated Hospital of China Medical University Shenyang, China. Written informed consent was obtained from the participants.

Statistical analysis
--------------------

All data were shown as mean ± SD. The fold change value and *P*-value were used to evaluate the differences of lncRNAs, miRNAs and mRNAs expression between GC tissues with and without *Hp* infection. False discovery rate (FDR) was calculated to correct the *P*-value. Student\'s t tests were used to analyze the differences of real-time PCR results. *P*\<0.05 was considered as statistically significant.

Results
=======

Identification of differentially expressed lncRNAs, miRNAs, mRNAs
-----------------------------------------------------------------

By differential analysis, we identified 32 DEmiRNAs and 462 DERNAs from miRNA-seq and RNA-seq of TCGA (The heat maps of them were shown in Fig. [2](#F2){ref-type="fig"}A and Fig. [2](#F2){ref-type="fig"}B). Twenty-one out of 32 DEmiRNAs were down-regulated and 11 were up-regulated. Excluding those RNAs that could not be defined or annotated by BIOMART, there were 27 DElncRNAs (24 DElncRNAs down-regulated and 3 up-regulated) and 257 DEmRNAs screened out. Top ten of DEmiRNAs and DElncRNAs were listed in Table [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}, respectively.

Establishment of ceRNAs regulatory network
------------------------------------------

Based on the theory of ceRNA network, we built the regulation loops with lncRNAs-miRNAs and miRNAs-mRNAs regulation pairs. In order to establish lncRNA-miRNA-mRNA network, we focused on whether those DEmiRNAs had interaction with DElncRNAs and DEmRNAs respectively, which means DEmiRNAs could target on them. After prediction by DIANA-LncBase v2, we found 11 DElncRNAs which might be targeted by 10 DEmiRNAs. Then, through TargetScanHuman and miRWalk, 219 DEmRNAs were predicted to be targets of those 10 common DEmiRNAs.

According to the above results, we chose intersectant 11 DElncRNAs (LINC01361, AC005150.1, LINC01524, MIR137HG, LINC01287, LINC01524, LINC01254, AC011525.2, LINC00408, LINC00645, U95743.1, LINC00922), 10 DEmiRNAs (miR-1286, miR-302b-5p, miR-3150b-3p, miR-7156-3p, miR-302a-5p, miR-378g, miR-3065-5p, miR-302c-5p, miR-7156-5p, miR-4740-5p) and 219 DEmRNAs to build lncRNAs-miRNAs-mRNAs regulatory ceRNA network. And the Cytosacpe was used to draw the network for visualization (Fig. [3](#F3){ref-type="fig"}).

The cellular functions and pathway analysis of DEmRNAs involved in ceRNA network
--------------------------------------------------------------------------------

The GO analysis indicated that the 219 differentially expressed mRNAs involved in ceRNA network parcitipated in biological process of sequence-specific DNA binding, serine-type endopeptidase, metalloendopeptidase, chloride channel, and structural molecular. Molecular function enriched these genes in intermediate filament, metabolic process, cytoskeleton organization, chloride transmembrane transport, brain development, female pregnancy, epidemis development, proteolysis, keratinization, negative regulation of endopeptidase activity, keratinocyte differentiation, and peptide cross-linking. In addition, cellular component suggested enrichment mainly at extracellular space, extracellular exosome, apical plasma membrane, extracellular region, keratin filament, and comified envelope (Fig. [4](#F4){ref-type="fig"}). KEGG pathway enrichment analysis revealed that the most significant pathways were P13K-Akt signaling pathway and renin secretion (shown in Table [3](#T3){ref-type="table"}). The PPI network was achieved, containing 109 nodes and 35 edges. According to the network, there were 6 hub genes (NTS, APOC3, OTX2, KRT13, CALCA, GNG4) and the gene with the highest degree (degree=8) was NTS (neurotensin, NTS), which could be seen in Fig. [5](#F5){ref-type="fig"}.

The Prognostic analysis of lncRNAs, miRNAs involved in ceRNA network
--------------------------------------------------------------------

To further analyze the prognostic characteristics of 11 DElncRNAs and 10 DEmiRNAs, the data set and the overall survival information were profiled by univariate Cox regression. We found that 4 DElncRNAs and 4 DEmiRNAs were significantly associated with the survival of *Hp* positive GC patients (*P*\<0.05), which were shown in Fig.[6](#F6){ref-type="fig"}. It showed that LINCO1254, LINCO1287, LINCO1524, U95743.1 were negatively associated with overall survival, and the associations of miR-302a, miR-302b, miR-1286, miR-378g were positively.

The verification of DElncRNAs
-----------------------------

To further validate above results, we chose fresh tissues of 30 gastric cancer patients, detecting and analyzing the expression levels of 4 prognostic related lncRNAs that were involved in *Hp* positive ceRNA network. According to the results, the levels of LINCO1254, LINCO1287, LINCO1524, U95743.1 were significantly higher in *Hp* positive GC patients than *Hp* negative patients (*P*=0.02, 0.048, 0.04, 0.036, respectively). And the results from qRT-PCR validation were completely consistent with bioinformatics analysis ones (Fig. [7](#F7){ref-type="fig"}).

Discussion
==========

In the present study, we identified cancer specific lncRNA and miRNA in GC with and without *Hp* infection by bioinformatics analysis using TCGA database, then built related ceRNA network. Besides, we predicted cellular functions and pathways of DEmRNAs involved in ceRNA network by GO and Pathway analysis. Moreover, the correlation between those DElncRNAs, DEmiRNA and overall survival were also explored. The ceRNA network we built provided a new thought of exploring the pathogenic mechanism and the survival analysis of GC with *Hp* infection.

In recent years, post-transcriptional regulation of non-coding RNAs has become a hot issue in the field of oncology [@B13]. Recent studies about miRNA and lncRNA have expanded our insights into *Hp* pathogenesis. Chang et al. suggested that miR-99b-3p, miR-564, and miR-638 were significantly increased in *Hp*-positive cancer tissues compared to the *Hp*-negative cancer tissues, while miR-204-5p, miR-338-5p, miR-375, and miR-548c-3p were significantly increased in *Hp*-negative cancer tissues [@B14]. Also, Zhu et al. reported they identified a number of differentially expressed lncRNAs in *Hp*-infected gastric mucosa tissues, and their data suggested that these lncRNAs might be involved in the pathological responses and development of *Hp*-related disorders and diseases.[@B6] In our study, based on the RNA sequence of TCGA database, we detected miRNA, lncRNA, and mRNA expression of GC with and without *Hp* infection. We found 27 differentially expressed lncRNAs, 32 differentially expressed miRNAs, and 257 differentially expressed mRNAs after comparing 168 patients with *Hp* negative GC patients and 20 patients with *Hp* positive GC. We newly found that these genes might be involved in regulating of the development of GC with *Hp* infection.

Competitive endogenous RNA (ceRNA) represents a novel layer of gene regulation that contribute to the physiology and development of diseases such as cancer, the dysregulation of which could lead to carcinogenesis [@B7]. Addressing this, in the present study we predicted DEmRNAs and DEmiRNA regulatory through miRWalk 3.0, TargetScanHuman 7.1, DEmiRNAs and DElncRNAs regulation through DIANA-LncBase v2. Next, we selected the intersectant DElncRNAs and DEmiRNAs with opposite expression trends, as well as DEmiRNAs and DEmRNAs. In the end, we constructed the ceRNA network of *Hp* positive GC by bioinformatics prediction and co-relation analysis of above differentially expressed RNAs, which eventually included intersectant 11 DElncRNAs, 10 DEmiRNAs and 219 DEmRNAs in co-expression network. Some researchers infer that *Hp* might regulate and control the expression of lncRNA through its toxin or other virulence factor, as what could also be found in the report of Zhu et al. that lncRNA might play key roles in the development of *Hp*-associated disorders and diseases through interaction with many other transcripts[@B6]. In addition, Yang et al. reported that immune response was confirmed to be dominant in *Hp*-positive GC, which was linked to lncRNA was overexpression [@B15]. However, until now, there is not any report about ceRNA network of *Hp* positive GC. Our analyses revealed that ceRNA regulation based on lncRNA-microRNA-mRNA is a complex and sophisticated mechanism, and might demonstrate essential regulatory role in the development of GC with *Hp* infection. Future biological studies might provide more detailed information and carry out essential clues for complex ceRNA regulation.

Then we predicted cellular functions and pathway analysis of DEmRNAs, which were involved in the ceRNA network. GO analysis indicated enrichment in biological process of sequence-specific DNA binding, serine-type endopeptidase, metalloendopeptidase, chloride channel, and structural molecular, which reminded us that *Hp* might contribute to the process of DNA binding and peptide cleavage. Cellular component suggested main enrichment at extracellular space, extracellular exosome, apical plasma membrane, extracellular region, keratin filament, and comified envelope. The obvious enrichment at extracellular exosome indicated that exosomes might be involved in the development of gastric and extragastric disorders associated with *Hp* infection, which should be focused on in the future [@B16]. In addition, intermediate filament, brain development, proteolysis, negative regulation of endopeptidase activity, keratinocyte differentiation, and peptide cross-linking were predominantly dysfunctional molecular function. As the most significant difference was proteolysis, it is reasonable to infer that *Hp* actively interferes with host cells by activating cellular proteases and the secretion of bacterial proteases, which has also been reported before [@B17]. As for the pathway, the results suggested that cancer-related pathway \'PI3K-Akt signaling pathway\' has the most significant difference. And this pathway has already been reported to be associated with *Hp* infection that virulent factor of *Hp,* like*CagA* could inhibit the autophagy through PI3K-Akt signaling pathway to promote gastric inflammation, in turn, promote gastric carcinogenesis. Liu *et al* and Ren *et al*, also found \'PI3K-Akt signaling pathway\' was related with GC cell functions.[@B18]-[@B20] About other pathways, like carbohydrate digestion and absorption, galactose metabolism, suggested that these metabolic processes might exert antimicrobial activity and have effect on *Hp* infection. From PPI network we built, we selected 6 hub genes, and the gene with the highest degree was NTS (neurotensin), regulated by miR-7156-5p. There is evidence that NTS contributes to the pathogenesis of*Hp* infection. The presence of *Hp* tends to alter the gastrointestinal hormone pattern, inducing neurotensin. And neurotensin is known to inhibit postprandial activity, effecting on some symtoms, like postprandial fullness [@B21].

At last, we explored the association between overall survival time and DElncRNAs, DEmiRNAs involved in the ceRNA network we built, respectively. We found from results that 4 DElncRNAs (LINC01254, LINC01287, LINC01524, U95743.1) and 4 DEmiRNAs (miR-302b, miR-302a, miR-378g, miR-1286) were related to *Hp* positive GC patients\' survival. Among them, miR-302b and miR-302a have been reported to show associations with the survival of GC [@B22]. In addition, miR-302a may also be involved in endometrial cancer and hepatocellular carcinoma [@B23], [@B24]. MiR-378g has been reported to be involved in bladder urothelial carcinoma [@B25], while miR-1286 could associate with breast cancer and cervical cancer [@B26], [@B27]. There were few reports about the relationship between lncRNA and the survival of GC or other kinds of cancer, and lncRNAs (LINC01254, LINC01287, LINC01524, U95743.1) have not been reported yet. The results of lncRNAs, miRNA and overall survival revealed potential indictors of prognosis in*Hp* positive GC. In addition, we chose fresh tissues of 30 gastric cancer patients, detecting and analysing the expression level of 4 prognostic related lncRNAs that were involved in *Hp* positive ceRNA network. Results revealed that LINC01254, LINC01287, LINC01524, U95743.1 were expressed higher in *Hp* positive GC tissue than in *Hp* negative GC tissue which was in agreement with the results from TCGA, and showed that our bioinformatics analysis was incredible.

However, the limitation should be acknowledged in this study. The sample size of gastric cancer with *Hp* infection was relatively small for the pooled analysis of comparing with gastric cancer without *Hp* infection. So the results still need future large-scale researches to confirm.

Conclusions
===========

Here we carried out a comprehensive analysis of aberrantly expressed ceRNA network in GC with and without *Hp* infection by bioinformatics analysis using TCGA database, and built the ceRNA regulatory network, which included 11lncRNAs, 10RNAs and 218mRNAs. We suggested the ceRNA regulatory network is associated with diseases pathways and essential cellular functions. Moreover, the prognostic analysis revealed that lncRNAs (LINC01254, LINC01287, LINC01524, U95743.1) and miRNAs (miR-302b, miR-302a, miR-378g, miR-1286) may be considered as potential specific biomarkers in diagnosis and prognosis of *Hp* positive GC, which could be continually validated and explored in our future study. Furthermore, the real-time PCR verification revealed that LINC01254, LINC01287, LINC01524, U95743.1 might be considered as potential biomarkers in the diagnosis and prognosis of GC with *Hp* infection. As far as I concerned, there are seldom reports that studied functional lncRNA induced by *Hp* infection. Besides, it has few reports about ceRNA network related to *Hp* infection until now. All together, we expect the study presented here brings biological insights into the essential roles of ceRNA regulation in GC with *Hp* infection.
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![The flow of the bioinformatics analysis.](jcav10p0853g001){#F1}
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The heat maps of the expression of DEmiRNAs(A) and DEmRNAs, DElncRNAs(B).
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![The differentially expressed lncRNA-miRNA-mRNA regulatory network in gastric cancer with and without *Hp* infection. Red octagon represents miRNA. Blue diamond represents lncRNA and green ellipse represents mRNA.](jcav10p0853g004){#F3}

![GO functional enrichment analyse for DEGs involved in the ceRNA network (the bar plot shows the enrichment scores of the significant enrichment pathways), mainly including three components, which are biological process, cellular component and molecular function.](jcav10p0853g005){#F4}

![Protein-protein interaction (PPI) network for DEGs involved in the ceRNA network. Colored nodes: query proteins and first of interactors. Empty nodes: proteins of unknown 3D structure. Filled nodes: some 3D structure is known or predicted. Edges represent protein-protein associations. Pink represents experimentally determined, green represents gene neighborhood, wathet-blue represents from curated database, dark blue represents gene co-occurrence, red represents gene fusions, and black represents co-expression.](jcav10p0853g006){#F5}
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A. Kaplan-Meier survival curvers for 4 DEmiRNAs associated with overall survival. Vertical axis represents survival rate, and horizontal axis represents survival time (year). B. for 4 DElncRNAs.
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![Quantitative RT-PCR validation of four differentially expressed lncRNAs. Relative expression levels of 4DElncRNAs are compared between *Hp*^+^ and *Hp*^-^ group by △CT value (shown as mean+SD). *P*\<0.05 is represented by \*.](jcav10p0853g009){#F7}

###### 

Top 10 differential expressed miRNAs

  Gene (miRNA)    Log FC         *P* Value     FDR
  --------------- -------------- ------------- -------------
  hsa-mir-302b    4.800417487    2.11E-12      3.15E-09
  hsa-mir-302a    4.73040372     4.65E-12      3.47E-09
  hsa-mir-302d    4.153060037    1.52E-09      7.59E-07
  hsa-mir-302c    2.544240507    1.66E-05      0.006186252
  hsa-mir-6715a   2.059531155    6.76E-05      0.016809501
  hsa-mir-372     -7.359051955   0.000100736   0.021485649
  hsa-mir-122     -5.867951592   0.000367743   0.065727522
  hsa-mir-203a    -1.296017557   0.000420684   0.065727522
  hsa-mir-184     -3.183847141   0.001012429   0.116273608
  hsa-mir-373     -6.306192354   0.00114065    0.120854295

###### 

Top 10 differential expressed lncRNAs

  Gene (lncRNA)   Transcript ID     Log FC         *P* Value     FDR
  --------------- ----------------- -------------- ------------- -------------
  OVAAL           ENST00000442621   7.016856432    1.29E-28      1.36E-24
  LINC00922       ENST00000569736   4.112562259    6.05E-26      5.13E-22
  MYCNUT          ENST00000433810   4.475819305    3.08E-11      3.96E-08
  LINC01287       ENST00000454441   -5.141133564   2.65E-05      0.006442655
  LINC01254       ENST00000567609   -4.212536271   0.000106153   0.017152222
  LINC00645       ENST00000557359   -4.448490725   0.000310739   0.03564988
  U95743.1        ENST00000573369   -3.964689472   0.000395919   0.040290509
  LINC01361       ENST00000452834   -3.079983301   0.000474201   0.044370481
  LINC01524       ENST00000454600   -3.257166236   0.000892848   0.062906349
  AC005307.1      ENST00000567877   -3.505146705   0.001012023   0.067363162

###### 

Significantly KEGG pathways for DEGs

  Pathway ID   Description                             Genes                                       *P* Value    FDR
  ------------ --------------------------------------- ------------------------------------------- ------------ ------------
  hsa04924     Renin secretion                         CLCA2, CLCA1, CLCA4, CALML3, CACNA1D        6.30E-04     0.70462716
  hsa04973     Carbohydrate digestion and absorption   G6PC, SLC2A2, CACNA1D, LCT                  0.00217633   2.41508175
  hsa00052     Galactose metabolism                    LALBA, G6PC, LCT                            0.01473533   15.3441269
  hsa04911     Insulin secretion                       KCNU1, GPR119, SLC2A2, CACNA1D              0.01556108   16.1368598
  hsa04151     PI3K-Akt signaling pathway              FGF19, CSH1, G6PC, PRLR, VTN, GNG4, FGF20   0.01894243   19.3129631
  hsa04972     Pancreatic secretion                    SLC26A3, CLCA2, CLCA1, CLCA4                0.01975617   20.0607696
  hsa04930     Type II diabetes mellitus               IRS4, SLC2A2, CACNA1D                       0.03561557   33.4311427
  hsa04917     Prolactin signaling pathway             CYP17A1, PRLR, SLC2A2                       0.07177503   56.6452718
  hsa04022     cGMP-PKG signaling pathway              IRS4, KCNU1, CALML3, CACNA1D                0.08363079   62.4688182
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